AR017518A1 - AN IL-1RD9 ISOLATED OR RECOMBINANT POLYPEPTIDE, A FUSION PROTEIN, A COMPOSITION, A KIT, A METHOD TO PRODUCE AN ANTIBODY, A COMPOSITION OF THE MATTER, A SUBSTANTIALLY PURE OR ISOLATED POLYPEPTIDE, A COMPOSITE TO A RECOVERED COMPOSITION CODE A PROTEIN - Google Patents
AN IL-1RD9 ISOLATED OR RECOMBINANT POLYPEPTIDE, A FUSION PROTEIN, A COMPOSITION, A KIT, A METHOD TO PRODUCE AN ANTIBODY, A COMPOSITION OF THE MATTER, A SUBSTANTIALLY PURE OR ISOLATED POLYPEPTIDE, A COMPOSITE TO A RECOVERED COMPOSITION CODE A PROTEINInfo
- Publication number
- AR017518A1 AR017518A1 ARP980105111A ARP980105111A AR017518A1 AR 017518 A1 AR017518 A1 AR 017518A1 AR P980105111 A ARP980105111 A AR P980105111A AR P980105111 A ARP980105111 A AR P980105111A AR 017518 A1 AR017518 A1 AR 017518A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- isolated
- polypeptide
- protein
- fusion protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Un polipéptido IL-1RD9 aislado o recombinante que: a) formado por el Nr ID de Sec: 6, 8, 10, 12, 14 o 16; b) codificado por un polinucleotido quecomprende al cuadro de lectura abierto del Nr ID de Sec: 5, 7, 9, 1, 13 o 15; o c) codificado por medio de una variante alélica natural de un polinucleotidoque comprende al cuadro de lectura abierto del Nr. ID de SEC: 5, 7, 9, 11, 13 o 15; una proteína de fusion, una composicion, un kit, método para producirun anticuerpo, una composicion de la materia,un polipéptido sustancialmente puro o asilado, un compuesto de enlace, un ácido nucleico aislado orecombinantes que codifica a una proteína o péptido de fusion, una célula transfectada, y un método para modular la fisiología o desarrollo de unacélulao células de cultivo de tejido.An isolated or recombinant IL-1RD9 polypeptide that: a) formed by the Nr ID of Sec: 6, 8, 10, 12, 14 or 16; b) encoded by a polynucleotide that comprises the open reading box of the Nr ID of Sec: 5, 7, 9, 1, 13 or 15; or c) encoded by means of a natural allelic variant of a polynucleotido which comprises the open reading frame of SEQ ID NO: 5, 7, 9, 11, 13 or 15; a fusion protein, a composition, a kit, a method of producing an antibody, a composition of the matter, a substantially pure or isolated polypeptide, a binding compound, an isolated orcombinant nucleic acid encoding a fusion protein or peptide, a transfected cell, and a method to modulate the physiology or development of a cell or tissue culture cells.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95182997A | 1997-10-15 | 1997-10-15 | |
| US97163597A | 1997-11-17 | 1997-11-17 | |
| US7800898P | 1998-03-12 | 1998-03-12 | |
| US4071498A | 1998-03-18 | 1998-03-18 | |
| US8188398P | 1998-04-15 | 1998-04-15 | |
| US9598798P | 1998-08-10 | 1998-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR017518A1 true AR017518A1 (en) | 2001-09-12 |
Family
ID=27556387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980105111A AR017518A1 (en) | 1997-10-15 | 1998-10-14 | AN IL-1RD9 ISOLATED OR RECOMBINANT POLYPEPTIDE, A FUSION PROTEIN, A COMPOSITION, A KIT, A METHOD TO PRODUCE AN ANTIBODY, A COMPOSITION OF THE MATTER, A SUBSTANTIALLY PURE OR ISOLATED POLYPEPTIDE, A COMPOSITE TO A RECOVERED COMPOSITION CODE A PROTEIN |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1029043A1 (en) |
| JP (1) | JP2004512801A (en) |
| AR (1) | AR017518A1 (en) |
| AU (1) | AU9786498A (en) |
| CA (1) | CA2306455A1 (en) |
| WO (1) | WO1999019480A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999032629A1 (en) * | 1997-12-23 | 1999-07-01 | Immunex Corporation | Tigirr dna and polypeptides |
| ES2245085T3 (en) | 1998-01-23 | 2005-12-16 | Immunex Corporation | ACPL DNA AND POLYPEPTIDES |
| US20020155526A1 (en) | 1998-09-30 | 2002-10-24 | Busfield Samantha J. | Novel secreted immunomodulatory proteins and uses thereof |
| KR20210032401A (en) | 2018-07-16 | 2021-03-24 | 리제너론 파마슈티칼스 인코포레이티드 | Anti-IL36R antibody |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10508743A (en) * | 1994-09-09 | 1998-09-02 | ニューロクライン バイオサイエンシーズ， インコーポレイテッド | Interleukin-1 type 3 receptor |
-
1998
- 1998-10-14 WO PCT/US1998/020939 patent/WO1999019480A2/en not_active Application Discontinuation
- 1998-10-14 JP JP2000516032A patent/JP2004512801A/en not_active Withdrawn
- 1998-10-14 EP EP98952080A patent/EP1029043A1/en not_active Withdrawn
- 1998-10-14 AR ARP980105111A patent/AR017518A1/en unknown
- 1998-10-14 AU AU97864/98A patent/AU9786498A/en not_active Abandoned
- 1998-10-14 CA CA002306455A patent/CA2306455A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999019480A3 (en) | 1999-06-24 |
| JP2004512801A (en) | 2004-04-30 |
| WO1999019480A2 (en) | 1999-04-22 |
| CA2306455A1 (en) | 1999-04-22 |
| EP1029043A1 (en) | 2000-08-23 |
| AU9786498A (en) | 1999-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9712077A (en) | High level protein expression | |
| DK0851868T3 (en) | High-level expression of proteins | |
| AR017510A1 (en) | ISOLATED OR RECOMBINANT POLYCUCLEOTIDE, EXPRESSION VECTOR, GUEST CELL, METHOD FOR PREPARING AN ANTIGEN POLYPEPTIDE, METHOD AND EQUIPMENT FOR LADETECTION OF A POLINUCLEOTIDE, UNION COMPOUND, METHOD OF EMPLOYMENT OF A COMPOSITE OPTIMETED SUBSTITUTE | |
| DE69535147D1 (en) | OVEREXPRESSION OF MAMMAL AND VIRUS PROTEINS | |
| DK0782625T3 (en) | Expression and export technology for proteins such as immune fusins | |
| NZ238056A (en) | Surface protein of metastasis forming tumour cells, related polypeptides, dna encoding these, antibodies, assays and pharmaceuticals | |
| ATE320495T1 (en) | CALCIUM-FREE SUBTILISIN MUTANTS | |
| ATE196651T1 (en) | DNA CODING FOR THE ALPHA-1E SUBUNIT OF THE HUMAN CALCIUM CHANNEL | |
| ATA192895A (en) | PRODUCTION OF PROTEINS FROM PRO-PROTEINS BY FUSION PROTEINS DERIVED FROM FURIN OR FURINANALOGS | |
| PE96899A1 (en) | ISOLATED GENES OF MAMMAL MEMBRANE PROTEINS; RELATED REAGENTS | |
| DK1114156T3 (en) | Transforming growth factor Beta-9 (ZTGFSS9) from mammals | |
| AR017518A1 (en) | AN IL-1RD9 ISOLATED OR RECOMBINANT POLYPEPTIDE, A FUSION PROTEIN, A COMPOSITION, A KIT, A METHOD TO PRODUCE AN ANTIBODY, A COMPOSITION OF THE MATTER, A SUBSTANTIALLY PURE OR ISOLATED POLYPEPTIDE, A COMPOSITE TO A RECOVERED COMPOSITION CODE A PROTEIN | |
| ZA916171B (en) | Protein structure of the plant toxin gelonin | |
| AU2001275267A1 (en) | Leader peptides for enhancing secretion of recombinant protein from a host cell | |
| ZA978503B (en) | Vertebrate smoothened proteins | |
| DE69634757D1 (en) | VECTOR FOR THE EXPRESSION OF N-TERMINAL EXTENDED PROTEINS IN HEF-CELLS | |
| HUP9903959A2 (en) | Truncated platelet-activating factor acetylhydrolase | |
| ES2170051T3 (en) | PROCEDURE FOR THE PRODUCTION OF PROTEINS USING FUSIONED PROTEINS OF TYPE CKS. | |
| AU654155B2 (en) | A DNA encoding a protein which binds to the enhancer of alpha-fetoprotein gene | |
| EP0750040A3 (en) | Macrophage stimulating protein variant and method for producing the same | |
| WO2001016144A3 (en) | Plant derived calcium-dependent calmodulin-binding polypeptides and polynucleotides encoding same | |
| EP0290029A3 (en) | (19-alanine) calcitonin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |